市场调查报告书
商品编码
1390572
2023-2028 年按设备技术、应用、最终用户和地区分類的消融设备市场报告Ablation Devices Market Report by Device Technology, Application, End User, and Region 2023-2028 |
2022年全球消融器械市场规模达52亿美元。展望未来, IMARC Group预计到2028年市场规模将达到102亿美元,2022-2028年复合年增长率(CAGR)为11.88%。危及生命的疾病的日益流行、电生理学去除异常组织的广泛采用,以及带有机器人导航系统的下一代消融设备的开发,是推动市场发展的一些关键因素。
消融装置是在各种医疗程序中用于移除或破坏组织的医疗器械或工具,通常目的是治疗或控制某些医疗状况。这些设备的工作原理是将热、冷或射频等能量传递到目标组织,导致其被去除或改变。消融手术是微创手术,通常比传统手术方法更受青睐,因为它们通常可以减轻疼痛、缩短恢復时间并降低併发症的风险。
该市场正在经历由几个关键因素推动的成长,包括癌症、心房颤动和慢性静脉功能不全(CVI)等危及生命的疾病的盛行率不断上升。疾病发生率的上升凸显了对有效消融手术的需求。此外,大众对微创消融技术可用性的认识不断增强,正在推动市场扩张。这些手术具有许多优点,包括减轻疼痛、最小化疤痕、减少不适以及加速患者康復时间。此外,广泛采用电生理学程序透过移除异常组织来解决心律不整和心律不整,这对市场成长做出了重大贡献。此外,製造商还透过开发专为有效治疗浅静脉逆流而设计的非热、非肿胀和非硬化静脉内消融装置来应对不断变化的医疗需求。
危及生命的疾病的盛行率不断增加
癌症仍然是全世界死亡的主要原因之一,近年来发病率不断上升。消融手术,特别是在肿瘤学领域,作为手术的微创替代方案而受到重视。它们被用来破坏各种器官中的癌组织,例如肝臟、肾臟和肺臟。此外,CVI 是一种腿部静脉无法将血液充分返回心臟的疾病,导致疼痛、肿胀和皮肤变化。静脉内消融手术现在通常用于透过封闭故障静脉来治疗 CVI。 CVI 发病率的上升通常与生活方式因素和衰老有关,这推动了对用于静脉治疗的消融设备的需求。
电生理学的广泛采用
电生理学是心臟病学的一个分支,研究心臟的电活动。由于其在诊断和治疗包括心房颤动在内的各种心律不整方面的有效性,它的采用率激增。电生理学引导的消融手术涉及精确定位和消除心臟中异常电信号的来源。这种方法已成为许多心律不整的护理标准,为患者提供缓解症状和提高生活品质的机会。此外,随着医疗保健专业人员越来越认识到电生理引导消融的好处,其采用已经广泛,导致对相关消融装置和设备的需求不断增长。
下一代消融设备与机器人导航系统的集成
消融设备领域的技术进步是一个重要的驱动力。下一代消融设备采用机器人导航系统,可提高精准度、准确度和手术结果。机器人辅助消融可以实现更受控和更有针对性的组织消融,降低併发症的风险并改善患者的治疗效果。这些机器人系统提供治疗区域的即时成像和绘图,使医疗保健提供者能够更有信心地导航复杂的解剖结构。因此,这些先进消融设备的采用正在增加,特别是在寻求提供最先进治疗选择的医疗机构中。提高病人安全性和手术成功率的承诺进一步刺激了对这些设备的需求。
IMARC Group提供了全球消融设备市场报告各细分市场主要趋势的分析,以及 2023 年至 2028 年全球、区域和国家层面的预测。我们的报告根据设备技术、应用和最终用户对市场进行了分类。
射频设备
雷射/光烧蚀
超音波设备
冷冻消融设备
其他的
射频设备代表最常用的设备技术
该报告根据设备技术对市场进行了详细的细分和分析。这包括射频设备、雷射/光消融、超音波设备、冷冻消融设备等。根据该报告,射频设备占据了最大的份额。
射频消融术已在广泛的医疗应用中证明了有效性。它用于治疗心律不整(例如心房颤动)、肝臟肿瘤、肾臟肿瘤和慢性疼痛管理等疾病。这种多功能性使射频技术成为处理各种医学专业的医生的首选。此外,射频消融在医疗手术中有着安全、成功使用的悠久历史。该技术多年来不断完善,临床医生在其应用方面拥有丰富的经验。这种安全性和有效性的记录为医疗保健提供者和患者註入了信心。
癌症治疗
心血管疾病治疗
眼科治疗
妇科治疗
泌尿科治疗
整容手术
其他的
癌症治疗占据最大市场份额
报告还提供了基于应用程式的详细市场细分和分析。这包括癌症治疗、心血管疾病治疗、眼科治疗、妇科治疗、泌尿科治疗、整形手术等。报告称,癌症治疗占最大部分。
癌症是一种广泛流行的疾病,影响全球数百万人。它可以发生在各种器官和组织中,导致对有效治疗方案的高需求。由于人口老化和生活方式改变等因素,癌症发生率持续上升,对包括消融在内的癌症治疗方法的需求仍然很大。此外,消融技术已被证明在肿瘤学领域具有多种用途。这些手术可用于治疗原发性肿瘤和转移性病变,使其适用于不同阶段和类型的癌症。消融可用于多种器官,如肝臟、肾臟、肺臟和骨骼,为临床医生提供了广泛的治疗选择。
医院
门诊手术中心
其他的
医院占大部分市场份额
报告还提供了基于最终用户的详细市场细分和分析。这包括半导体和电子、汽车、航空航太和国防、医疗等。报告称,医院占最大部分。
消融手术通常需要专门的设备和训练有素的医疗专业人员。医院设备齐全,可以处理复杂的医疗干预措施,并拥有必要的基础设施,包括手术室、影像技术和支援人员,以安全有效地执行这些程序。这使得医院成为寻求消融治疗的患者的自然选择。此外,医院还拥有广泛的医学专科,包括心臟科、肿瘤学、胃肠病学、泌尿科等。消融设备用于多个医学学科来治疗各种病症。医院可以提供全面的消融服务,使其成为具有不同医疗需求的患者的一站式目的地。
北美洲
美国
加拿大
亚太
中国
日本
印度
韩国
澳洲
印尼
其他的
欧洲
德国
法国
英国
义大利
西班牙
俄罗斯
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
北美在市场上表现出明显的主导地位
市场研究报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,北美占据最大的市场份额。
北美,特别是美国和加拿大,拥有高度发展和先进的医疗基础设施。该地区拥有世界知名的医疗机构、医院和研究中心。这种先进的基础设施为采用尖端医疗技术(包括消融设备)提供了坚实的基础。此外,该地区是世界上医疗保健支出最高的地区之一。政府和私人实体对医疗保健的大量投资使得能够采购最先进的医疗设备,包括消融设备。它还支持医疗保健领域的研究和开发工作,从而促进创新和产品进步。
市场竞争格局的特点是存在多个参与者,包括知名品牌、新兴新创公司和专业製造商。目前,领先的公司正在投入大量资源进行研发工作,以开发创新且技术先进的消融设备。这包括开发具有更高精度、安全功能和用户友好介面的下一代消融系统。他们还扩大产品组合,提供全面的消融设备,以满足各种医疗专业和应用的需求。这包括设计用于心臟消融、肿瘤学、疼痛管理、妇科等的设备。此外,公司正在将业务范围扩大到新的地域市场。这种扩张涉及获得不同地区的监管批准和认证、建立分销网络以及调整其产品以满足特定地区的要求。
雅培实验室
血管动力学公司
阿特里库尔公司
波士顿科学公司
康迈德公司
Elekta AB(出版)
强生公司
美敦力公司
奥林巴斯公司
施乐辉公司
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
雅培在消融设备领域取得了显着的发展。他们推出了 EnSite Precision (TM) 心臟测绘系统,该系统可提供高解析度成像和准确的心臟测绘。此技术能够在消融过程中精确识别异常组织,提高治疗的成功率。
强生公司一直积极参与创新消融技术的开发。该公司推出了 TactiCath 接触力消融导管,可提供心臟消融手术期间施加的力量的即时回馈。这有助于实现更好的结果并降低併发症的风险。
美敦力公司推出了 Arctic Front Advance Cryoballoon 系统,用于治疗心房颤动。该系统提高了心臟消融手术的效率和精确度。
The global ablation devices market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 11.88% during 2022-2028. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
IMARC Group provides an analysis of the key trends in each segment of the global ablation devices market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on device technology, application and end user.
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Others
Radiofrequency devices represent the most used device technology
The report has provided a detailed breakup and analysis of the market based on the device technology. This includes radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. According to the report, radiofrequency devices represented the largest segment.
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Others
Cancer treatment holds the largest market share
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. According to the report, cancer treatment represented the largest segment.
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals
Ambulatory Surgical Centers
Others
Hospitals accounts for majority of market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes semiconductor and electronics, automotive, aerospace and defense, medical, and others. According to the report, hospitals represented the largest segment.
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
Abbott Laboratories
AngioDynamics Inc.
AtriCure Inc.
Boston Scientific Corporation
CONMED Corporation
Elekta AB (publ)
Johnson & Johnson
Medtronic plc
Olympus Corporation
Smith & Nephew plc
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Abbott has made notable developments in the field of ablation devices. They have introduced the EnSite Precision™ cardiac mapping system, which offers high-resolution imaging and accurate mapping of the heart. This technology enables precise identification of abnormal tissue during ablation procedures, improving the success rate of the treatment.
Johnson & Johnson has been actively involved in the development of innovative ablation technologies. It has introduced the TactiCath Contact Force Ablation Catheter, which provides real-time feedback on the amount of force applied during cardiac ablation procedures. This helps in achieving better outcomes and reducing the risk of complications.
Medtronic Plc have introduced the Arctic Front Advance Cryoballoon System, which is used for the treatment of atrial fibrillation. This system offers improved efficiency and precision in cardiac ablation procedures.